These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34988890)

  • 1. Scutellarein protects against cardiac hypertrophy via suppressing TRAF2/NF-κB signaling pathway.
    Shi X; Hu Y; Jiang Y; Wu J; Zhang C; Zhang J; Wu S; Wu Y; Dong W; Li J
    Mol Biol Rep; 2022 Mar; 49(3):2085-2095. PubMed ID: 34988890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lupeol protects against cardiac hypertrophy via TLR4-PI3K-Akt-NF-κB pathways.
    Li D; Guo YY; Cen XF; Qiu HL; Chen S; Zeng XF; Zeng Q; Xu M; Tang QZ
    Acta Pharmacol Sin; 2022 Aug; 43(8):1989-2002. PubMed ID: 34916609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oleanonic acid ameliorates pressure overload-induced cardiac hypertrophy in rats: The role of PKCζ-NF-κB pathway.
    Gao H; Liu H; Tang T; Huang X; Wang D; Li Y; Huang P; Peng Y
    Mol Cell Endocrinol; 2018 Jul; 470():259-268. PubMed ID: 29138023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte immunoglobulin-like receptor B4 protects against cardiac hypertrophy via SHP-2-dependent inhibition of the NF-κB pathway.
    Zhou H; Li N; Yuan Y; Jin YG; Wu Q; Yan L; Bian ZY; Deng W; Shen DF; Li H; Tang QZ
    J Mol Med (Berl); 2020 May; 98(5):691-705. PubMed ID: 32280997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
    Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
    PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pinoresinol diglucoside (PDG) attenuates cardiac hypertrophy via AKT/mTOR/NF-κB signaling in pressure overload-induced rats.
    Chen Y; Pan R; Zhang J; Liang T; Guo J; Sun T; Fu X; Wang L; Zhang L
    J Ethnopharmacol; 2021 May; 272():113920. PubMed ID: 33607200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
    Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
    Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-κB signaling.
    Xiong Z; Sun G; Zhu C; Cheng B; Zhang C; Ma Y; Dong Y
    Eur J Pharmacol; 2010 Dec; 649(1-3):277-84. PubMed ID: 20863781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory pathways are activated during cardiomyocyte hypertrophy and attenuated by peroxisome proliferator-activated receptors PPARalpha and PPARdelta.
    Smeets PJ; Teunissen BE; Planavila A; de Vogel-van den Bosch H; Willemsen PH; van der Vusse GJ; van Bilsen M
    J Biol Chem; 2008 Oct; 283(43):29109-18. PubMed ID: 18701451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scutellarin exerts its anti-hypertrophic effects via suppressing the Ca2+-mediated calcineurin and CaMKII signaling pathways.
    Pan ZW; Zhang Y; Mei DH; Zhang R; Wang JH; Zhang XY; Xu CQ; Lu YJ; Yang BF
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Feb; 381(2):137-45. PubMed ID: 20052460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NAKα2 inhibits fibrosis formation and protects against cardiomyocyte hypertrophy by suppressing hypertrophy associated molecules and activating LTCC/NCX signaling pathway.
    Song SS; Tang G; Tang LX; Si LY; Xiong W
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):3021-3033. PubMed ID: 31002153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4/NF-κB Pathway in Mice.
    Nalban N; Sangaraju R; Alavala S; Mir SM; Jerald MK; Sistla R
    Cardiovasc Toxicol; 2020 Jun; 20(3):235-248. PubMed ID: 31485892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of TRPC1 prevents cardiac hypertrophy via NF-κB signaling pathway in human pluripotent stem cell-derived cardiomyocytes.
    Tang L; Yao F; Wang H; Wang X; Shen J; Dai B; Wu H; Zhou D; Guo F; Wang J; Li T; Wang H; Gong T; Su J; Wang L; Liang P
    J Mol Cell Cardiol; 2019 Jan; 126():143-154. PubMed ID: 30423318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways.
    Chen G; Pan SQ; Shen C; Pan SF; Zhang XM; He QY
    Acta Pharmacol Sin; 2014 Apr; 35(4):463-75. PubMed ID: 24608673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G3BP2 is involved in isoproterenol-induced cardiac hypertrophy through activating the NF-κB signaling pathway.
    Hong HQ; Lu J; Fang XL; Zhang YH; Cai Y; Yuan J; Liu PQ; Ye JT
    Acta Pharmacol Sin; 2018 Feb; 39(2):184-194. PubMed ID: 28816235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenoside Rg3 attenuates angiotensin II-induced myocardial hypertrophy through repressing NLRP3 inflammasome and oxidative stress via modulating SIRT1/NF-κB pathway.
    Ren B; Feng J; Yang N; Guo Y; Chen C; Qin Q
    Int Immunopharmacol; 2021 Sep; 98():107841. PubMed ID: 34153662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
    Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
    Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CaMKII activates ASK1 and NF-kappaB to induce cardiomyocyte hypertrophy.
    Kashiwase K; Higuchi Y; Hirotani S; Yamaguchi O; Hikoso S; Takeda T; Watanabe T; Taniike M; Nakai A; Tsujimoto I; Matsumura Y; Ueno H; Nishida K; Hori M; Otsu K
    Biochem Biophys Res Commun; 2005 Feb; 327(1):136-42. PubMed ID: 15629441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation.
    Zhu W; Wu RD; Lv YG; Liu YM; Huang H; Xu JQ
    Biomed Pharmacother; 2020 Jan; 121():109368. PubMed ID: 31707348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α₁ adrenoceptor activation by norepinephrine inhibits LPS-induced cardiomyocyte TNF-α production via modulating ERK1/2 and NF-κB pathway.
    Yu X; Jia B; Wang F; Lv X; Peng X; Wang Y; Li H; Wang Y; Lu D; Wang H
    J Cell Mol Med; 2014 Feb; 18(2):263-73. PubMed ID: 24304472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.